Infinitopes, a University of Oxford spinout, is trialling an experimental cancer vaccine designed to help the immune system recognise and attack oesophageal cancer.
www.cancer.ox.ac.uk/news/univers...
www.cancer.ox.ac.uk/news/univers...
University of Oxford spinout doses first patient in oesophageal cancer vaccine trial
The trial has administered the first in human experimental cancer vaccine designed to help the immune system recognise and attack oesophageal cancer.
www.cancer.ox.ac.uk
August 12, 2026 at 5:00 PM
Infinitopes, a University of Oxford spinout, is trialling an experimental cancer vaccine designed to help the immune system recognise and attack oesophageal cancer.
www.cancer.ox.ac.uk/news/univers...
www.cancer.ox.ac.uk/news/univers...
Lab space/ innovation latest: Infinitopes, the Oxford University spin-out developing vaccines for cancer is moving to ARC Oxford off Garsington Road as it scales up.
www.infinitopes.com
www.infinitopes.com
Positioned to deliver revolutionary off-the-shelf cancer vaccines
Empowering the Future
www.infinitopes.com
September 9, 2026 at 5:51 AM
Lab space/ innovation latest: Infinitopes, the Oxford University spin-out developing vaccines for cancer is moving to ARC Oxford off Garsington Road as it scales up.
www.infinitopes.com
www.infinitopes.com
Infinitopes began its first human clinical trial of its oesophageal cancer vaccine in July, and raised $35 million earlier this year.
It will be the first occupier of ARC Oxford's new Motherlabs fully fitted biological lab space. www.arcgroup.io/oxford/
It will be the first occupier of ARC Oxford's new Motherlabs fully fitted biological lab space. www.arcgroup.io/oxford/
Lab Space for Innovators
Discover state-of-the-art lab space in Oxford for your research & collaboration at our ARC Oxford Science Campus
www.arcgroup.io
September 9, 2026 at 5:51 AM
Infinitopes began its first human clinical trial of its oesophageal cancer vaccine in July, and raised $35 million earlier this year.
It will be the first occupier of ARC Oxford's new Motherlabs fully fitted biological lab space. www.arcgroup.io/oxford/
It will be the first occupier of ARC Oxford's new Motherlabs fully fitted biological lab space. www.arcgroup.io/oxford/
#Pharma #biotech #BoehringerIngelheim #AbbVie #Sensorion #LogicBioTherapeutics #ArgenX #Artios #ArtiosPharma #IovanceBiotherapeutics #AstronauTx #SarahCannonResearchInstitute #QuantitativeBiosciencesInstitute #QBI #ArtivaBiotherapeutics #MBXBiosciences #OSTherapies #Infinitopes
zurl.co/FS7kt
zurl.co/FS7kt
Changing Faces: Pharma and biotech hires, May 2026
Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.
pharmaphorum.com
July 2, 2026 at 9:14 AM
#China's #CorxelPharmaceuticals' latest round is further evidence of #biotech #investors' insatiable appetite for companies with #obesity programmes, with backers ploughing $287 million into its Series D.
Corxel's raises $287m for obesity drug, and other financings
Our latest biofinancing round-up sees big rounds for Corxel and Caldera, with Mendra, Think Bio, Exciva, Cytotheryx, and Infinitopes also raising cash.
buff.ly
January 23, 2026 at 1:00 PM
#China's #CorxelPharmaceuticals' latest round is further evidence of #biotech #investors' insatiable appetite for companies with #obesity programmes, with backers ploughing $287 million into its Series D.
Feed: "Endpoints News"
By: ENDPOINTS on Wednesday, January 21, 2026
By: ENDPOINTS on Wednesday, January 21, 2026
Tanabe pill delays blood disorder; enGene adds up to $100M from loans
Plus, news about IO, ErVimmune, Affibody, Clasp Therapeutics and Infinitopes.
endpoints.news
January 22, 2026 at 11:07 AM
Feed: "Endpoints News"
By: ENDPOINTS on Wednesday, January 21, 2026
By: ENDPOINTS on Wednesday, January 21, 2026
Infinitopes Raises $35 Million to Propel Cancer Vaccine Development and Transform Patient Care#United_Kingdom#Oxford#Cancer_Vaccine#Infinitopes#ITOP1
Infinitopes Raises $35 Million to Propel Cancer Vaccine Development and Transform Patient Care
Infinitopes has successfully raised a total of $35.1 million in seed funding, aimed at advancing its promising cancer vaccine ITOP1 towards clinical trials, targeting oesophageal cancer.
third-news.com
January 21, 2026 at 8:12 AM
Infinitopes Raises $35 Million to Propel Cancer Vaccine Development and Transform Patient Care#United_Kingdom#Oxford#Cancer_Vaccine#Infinitopes#ITOP1
Infinitopes Secures Approval for Groundbreaking Cancer Vaccine Clinical Trial in the UK#United_Kingdom#Oxford#Infinitopes#Oesophageal_Cancer#ITOP1
Infinitopes Secures Approval for Groundbreaking Cancer Vaccine Clinical Trial in the UK
Infinitopes Ltd has received UK regulatory approval to commence clinical trials for ITOP1, a novel vaccine targeting oesophageal cancer, showing promise in reducing recurrence rates.
third-news.com
April 9, 2025 at 7:36 AM
Infinitopes Secures Approval for Groundbreaking Cancer Vaccine Clinical Trial in the UK#United_Kingdom#Oxford#Infinitopes#Oesophageal_Cancer#ITOP1
Infinitopes Welcomes Two Leading Biotech Executives to Enhance Cancer Immunotherapy Development#United_Kingdom#Oxford#Infinitopes#Dan_Menichella#Jo_Brewer
Infinitopes Welcomes Two Leading Biotech Executives to Enhance Cancer Immunotherapy Development
Infinitopes announces new leadership as Dan Menichella and Dr. Jo Brewer join its Board to drive the development of precision immunotherapies for cancer treatment.
third-news.com
March 20, 2025 at 8:36 AM
Infinitopes Welcomes Two Leading Biotech Executives to Enhance Cancer Immunotherapy Development#United_Kingdom#Oxford#Infinitopes#Dan_Menichella#Jo_Brewer
Congrats to the Infinitopes team #spinout thebusinessmagazine.co.uk/technology-i...
Oxford spinout Infinitopes raises £12.8m to enhance antigen discovery tech
Infinitopes Precision Immunomics, an integrated cancer biotech, has completed a £12.8 million seed funding round led by Octopus Ventures. The round was ‘heavily oversubscribed’ and drew funds from...
thebusinessmagazine.co.uk
May 2, 2024 at 11:25 AM
Congrats to the Infinitopes team #spinout thebusinessmagazine.co.uk/technology-i...